Stock Events

Stock Events

IRulya Therapeutics (QNCX) Q2 2026 Earnings

May 11Confirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-26

7.87

41.73

75.6

Details

Expected EPS

-26

Actual EPS

75.6

Surprise EPS

101.6

Surprise Percent

+390.77%

Description

⁨IRulya Therapeutics⁩ (⁦QNCX⁩) has reported earnings of ⁦75.6⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.